Category Archives: Rheumatology

FDA CDER Director on Benlysta for lupus and adaptive clinical trials.

July 27, 2011- Janet Woodcock, MD, Director of the FDAs new drug division, CDER, discusses with Steven Greer,

Posted in - Biotech, - Pharma, FDA, Rheumatology | Leave a comment

Mepolizumab or Placebo for Eosinophilic Granulomatosis with Polyangiitis

May 23, 2017- interviewed by Steven E. Greer, MD We interviewed polumonologist Michael Wechsler, MD about his paper in the NEJM testing mepolizumab

Posted in - NEJM, National Jewish Health, Pulmonology, Rheumatology | Leave a comment